These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 2736519)

  • 1. Estimation of cell survival by flow cytometric quantification of fluorescein diacetate/propidium iodide viable cell number.
    Ross DD; Joneckis CC; Ordóñez JV; Sisk AM; Wu RK; Hamburger AW Nora RE; Nora RE
    Cancer Res; 1989 Jul; 49(14):3776-82. PubMed ID: 2736519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of highly multidrug-resistant P388 cells from drug-sensitive P388/S cells by flow cytometric cell sorting.
    Ross DD; Ordóñez JV; Joneckis CC; Testa JR; Thompson BW
    Cytometry; 1988 Jul; 9(4):359-67. PubMed ID: 3402281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug sensitivity assay for leukaemic cells by flow cytometry.
    Gupta M; Naik S; Pandey CM; Dabadghao S
    Indian J Med Res; 2002 Jun; 115():260-4. PubMed ID: 12440199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative measurements of the efficacy of new anti-cancer agents on fresh human AML cells by using multivariate flow analysis.
    Nakeff A; KuKuruga MA; Media JE; Valeriote F; Edelstein MB
    J Exp Ther Oncol; 1996 Nov; 1(6):361-7. PubMed ID: 9414426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of DiOC(6)(3) uptake and annexin V labeling for quantification of apoptosis in leukemia cells and non-malignant T lymphocytes from children.
    Ozgen U; Savaşan S; Buck S; Ravindranath Y
    Cytometry; 2000 Feb; 42(1):74-8. PubMed ID: 10679746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timed sequential therapy of acute leukemia with flavopiridol: in vitro model for a phase I clinical trial.
    Karp JE; Ross DD; Yang W; Tidwell ML; Wei Y; Greer J; Mann DL; Nakanishi T; Wright JJ; Colevas AD
    Clin Cancer Res; 2003 Jan; 9(1):307-15. PubMed ID: 12538483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new flow cytometric method for discrimination of apoptotic cells and detection of their cell cycle specificity through staining of F-actin and DNA.
    Endresen PC; Prytz PS; Aarbakke J
    Cytometry; 1995 Jun; 20(2):162-71. PubMed ID: 7545098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple, semiautomatic assay of cytostatic and cytotoxic effects of antitumor drugs by laser scanning cytometry: effects of the bis-intercalator WP631 on growth and cell cycle of T-24 cells.
    Pozarowski P; Huang X; Gong RW; Priebe W; Darzynkiewicz Z
    Cytometry A; 2004 Feb; 57(2):113-9. PubMed ID: 14750133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations of the fluorescent probe viability assay.
    Massaro EJ; Elstein KH; Zucker RM; Bair KW
    Mol Toxicol; 1989; 2(4):271-84. PubMed ID: 2490980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An improved method to determine cell viability by simultaneous staining with fluorescein diacetate-propidium iodide.
    Jones KH; Senft JA
    J Histochem Cytochem; 1985 Jan; 33(1):77-9. PubMed ID: 2578146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differential cell growth inhibition and terminal differentiation induction by chemotherapeutic agents of a human acute myelogenous leukemia cell line (HL-60) in vitro].
    Himori T; Ohnuma T; Wakui A
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1605-11. PubMed ID: 6591856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapeutic drug sensitivity testing of human leukemia cells in vitro using a semiautomated fluorometric assay.
    Larsson R; Nygren P; Ekberg M; Slater L
    Leukemia; 1990 Aug; 4(8):567-71. PubMed ID: 2388483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated fluorescent analysis for drug-induced cytotoxicity assays.
    Funa K; Dawson N; Jewett PB; Agren H; Ruckdeschel JC; Bunn PA; Gazdar AF
    Cancer Treat Rep; 1986 Oct; 70(10):1147-51. PubMed ID: 3019545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of flow-cytometric detection of multidrug-resistant cells by cell-volume normalization of intracellular daunorubicin content.
    Ross DD; Thompson BW; Ordóñez JV; Joneckis CC
    Cytometry; 1989 Mar; 10(2):185-91. PubMed ID: 2714107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrimination of viable and non-viable cells using propidium iodide in two color immunofluorescence.
    Sasaki DT; Dumas SE; Engleman EG
    Cytometry; 1987 Jul; 8(4):413-20. PubMed ID: 3113897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromodeoxyuridine enhancement of 1-beta-D-arabinofuranosylcytosine metabolic activation and toxicity in HL-60 leukemic cells.
    Ross DD; Joneckis CC; Song TH; Wu RK
    Cancer Res; 1988 Feb; 48(3):517-21. PubMed ID: 3335018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Flow cytometric studies of brain tumors--5: New sensitivity test of antineoplastic agents for brain tumors and its clinical application].
    Kawakami K; Kawamoto K; Oka N; Kawamura Y; Matsumura H; Ito T; Ohyama A
    No Shinkei Geka; 1986 Apr; 14(5):627-34. PubMed ID: 2425281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoro-Gold: An alternative viability stain for multicolor flow cytometric analysis.
    Barber L; Prince HM; Rossi R; Bertoncello I
    Cytometry; 1999 Aug; 36(4):349-54. PubMed ID: 10404151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric quantification of apoptosis and proliferation in mixed lymphocyte culture.
    Marín L; Minguela A; Torío A; Moya-Quiles MR; Muro M; Montes-Ares O; Parrado A; Alvarez-López DM; García-Alonso AM
    Cytometry A; 2003 Feb; 51(2):107-18. PubMed ID: 12541285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug testing in established cell lines by flow cytometric vitality measurements versus clonogenic assay.
    Ellwart JW; Kremer JP; Dörmer P
    Cancer Res; 1988 Oct; 48(20):5722-5. PubMed ID: 3167831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.